Serial Number | 99025787 |
Word Mark | CRENESSITY |
Filing Date | Friday, January 31, 2025 |
Status | 658 - PRIORITY ACTION MAILED |
Status Date | Monday, June 9, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of four lines with curved top and bottom edges that become progressively larger from left to right and form the overall shape of a conical seashell. The lines appear left to right in a gradient of color from purple to orange to yellow and are positioned above the word CRENESSITY. |
Goods and Services | Pharmaceutical preparations for the treatment of adrenal insufficiency; pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions |
Indication of Colors claimed | The color(s) purple, orange, and yellow is/are claimed as a feature of the mark. |
Goods and Services | Providing medical information; Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders |
Goods and Services | Providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders, for others; conducting post-authorization pharmaceutical research for the marketing of pharmaceutical preparations and evaluating epidemiological results |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 31, 2025 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 31, 2025 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 31, 2025 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Neurocrine Biosciences, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92130 |
Event Date | Event Description |
Friday, January 31, 2025 | NEW APPLICATION ENTERED |
Friday, January 31, 2025 | APPLICATION FILING RECEIPT MAILED |
Thursday, March 20, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Thursday, March 20, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, March 20, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Thursday, May 22, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Thursday, May 22, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, June 4, 2025 | ASSIGNED TO EXAMINER |
Monday, June 9, 2025 | PRIORITY ACTION WRITTEN |
Monday, June 9, 2025 | PRIORITY ACTION E-MAILED |
Monday, June 9, 2025 | NOTIFICATION OF PRIORITY ACTION E-MAILED |